Southeast Nebraska Cancer Center ( Site 0316) — Lincoln, Nebraska

Southeast Nebraska Cancer Center ( Site 0316) is a clinical research site located in Lincoln, Nebraska, United States 68510.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Southeast Nebraska Cancer Center ( Site 0316) has participated in 1 clinical trials.

Therapeutic areas: Advanced Melanoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Southeast Nebraska Cancer Center ( Site 0316)?

Southeast Nebraska Cancer Center ( Site 0316) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Southeast Nebraska Cancer Center ( Site 0316) conducted?

Southeast Nebraska Cancer Center ( Site 0316) has 1 clinical trials on record. Their work covers Advanced Melanoma.

Is Southeast Nebraska Cancer Center ( Site 0316) accredited by Crixeo Health?

Southeast Nebraska Cancer Center ( Site 0316) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Southeast Nebraska Cancer Center ( Site 0316)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.